Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF SEPTEMBER 02, 2016 FBO #5397
SPECIAL NOTICE

A -- Antimalarial Drugs on the Immune Response to Rabies Vaccine for Post-exposure Prophylaxis

Notice Date
8/31/2016
 
Notice Type
Special Notice
 
NAICS
541712 — Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
 
Contracting Office
Department of the Army, U.S. Army Medical Research Acquisition Activity, U.S. Army Medical Research Acquisition Activity, Attn: MCMR-AAA, 820 Chandler Street, Frederick, MD 21702-5014, Maryland, 21702-5014, United States
 
ZIP Code
21702-5014
 
Solicitation Number
10881498
 
Archive Date
9/29/2016
 
Point of Contact
Sharew Hailu, Phone: 301-619-9201
 
E-Mail Address
sharew.hailu.civ@mail.mil
(sharew.hailu.civ@mail.mil)
 
Small Business Set-Aside
N/A
 
Description
The United States Army Medical Research Acquisition Activity (USAMRAA) intends to negotiate on a sole source basis, IAW FAR 6.302-1(a), with the Research Foundation For The State University of New York (SUNY) as the only responsible source that can provide Walter Reed Army Institute of Research support to study the effect of current antimalarial medications used by DoD on the immune response to a licensed rabies vaccination. SCOPE OF WORK: The work items presented herein are associated with the technical, financial, logistical, and administrative support necessary for SUNY to execute the clinical studies over the period of performance September 2016 to January 2018. Specific study aims include: To determine the effects of the antimalarial prophylaxis drugs on the humoral immune responses to standard post-exposure rabies vaccination; To collect samples for future analysis should a significant difference in rabies titers be detected between groups taking or not taking antimalarials. The contractor will be responsible for finalizing preparation of the clinical trial site, executing the trial, and completing the required trial closeout activities in accordance with the clinical study protocols and applicable DoD and FDA regulations. Planned resumption of clinical activities is Q4 FY16.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/USA/USAMRAA/DAMD17/10881498/listing.html)
 
Place of Performance
Address: The Walter Reed Army Institute of Research (WRAIR), Siliver Spring, Maryland, 20910, United States
Zip Code: 20910
 
Record
SN04249426-W 20160902/160831235929-33e0838f393bc5c780961ab742c51d76 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.